Atlas Trials

Sorafenib Tosylate Following a Liver Transplant in Treating Patients With Liver Cancer

Clinical trial NCT01624285 · COMPLETED

Trial details

NCT number
NCT01624285
Sponsor
Jonsson Comprehensive Cancer Center
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Adult Primary Hepatocellular CarcinomaLocalized Resectable Adult Primary Liver CancerLocalized Unresectable Adult Primary Liver CancerRecurrent Adult Primary Liver Cancer
Start date
2012-07-16
Primary completion
2023-02-01
Enrollment
20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.